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To date the most important biomarkers for Multiple Sclerosis (MuS) diagnosis are the 
oligoclonal bands (OCBs) in CSF and Link Index. CSF is the body fluid that might better 
provide information about the pathological processes occurring in the CNS, because of its 
proximity. Anyway, it is obtained through an invasive procedure, thus tears, may repre-
sent an useful alternative source of biomarkers. Emerging evidences showed that distinct 
types of brain cells release high number of Extracellular Vesicles (EVs), that play impor-
tant roles in the CNS, and represent a relevant source of biomarkers, relative free from 
confounding factors. In the present study, we analysed EVs from MuS patients obtained 
from tears and CSF samples. In details, 50μl of CSF or 50 μl of tears/sample were pro-
cessed by a common flow cytometry no-lyse and no-wash method, in order to identify 
EVs. Exosomes and microvesicles (MVs) were sorted (70 μm nozzle, FACSAria III cell 
sorter, BD) from pooled CSF samples on the basis of their positivity to specific tetras-
painins (for exosomes) or markers identifying each MV subset. Fractions were analysed 
by electron microscopy and Dynamic Light Scattering. Purified MV fractions under-
gone to FASP tryptic digestion and nanoLC-ESI-QTOF-MS/MS based shotgun proteomic 
approach. Identified MVs proteins were processed by Ingenuity Pathway Analysis (IPA) 
and PANTHER - Gene List Analysis.
Our data shows the presence of subpopulations of extracellular MVs of neuronal and 
microglia origins in tears , indicating a cross talk between the two compartment. We also 
identified 55 proteins (FDR<2.38) for the MVs fraction. To uncover the molecular events 
underlying these proteins profiles, we studied the Gene Ontology (GO) information in 
terms of biological process and molecular function by using PANTHER software and we 
observed that about 70% of the identified proteins resulted were involved in binding pro-
cesses, while 40% of them were related to cell communication. Ingenuity Pathway Analy-
sis (IPA) of the identified MVs proteins revealed that the top network associated to them 
are “Cellular Movement, Hematological Disease, Immunological Disease”, well matching 
with MS. Among the upstream regulators, the most significant one is PRDM with a p-val-
ue of 6.68E-07. The remaining upstream regulators, including APOE (the most relevant 
lipid carrier protein in the brain involved in brain development and repair), well related 
to neurological disease. These data underlined that MVs form neuronal and microcglial 
origin are detectable not only in the CSF, but also in tears from MuS patients. Of note, 
MVs of CSF origin carry relevant targets involved in immune responses in MuS patients, 
therefore they might be proposed as useful tools in MuS diagnosis and characterization. 
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